10 March, 2025T-Therapeutics appoints Theodora Harold as Chief Executive Officer, reflecting Company’s ambitious growth plans and progression into therapeutic development
4 March, 2025Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
20 January, 2025Amid the buzz at JP Morgan conference, Sofinnova Partners' Antoine Papiernik is optimistic
10 January, 2025Mediar Therapeutics enters into global licensing agreement with Lilly to advance first-in-class WISP1 antibody for the treatment of idiopathic pulmonary fibrosis (IPF)
9 January, 2025Tenpoint Therapeutics announces positive topline data from Phase 3 pivotal study, BRIO-II, of BRIMOCHOL™ PF for the treatment of presbyopia